Closed call · historical reference
ARIA's "Sustained Viral Resilience" programme seeks to create a new class of medicines that provide durable, broad-spectrum protection against respiratory viruses by engineering the innate immune system. A call for proposals is now open, with concept papers due by 10 November 2025 and full proposal…
Topics
Partner types
research, startup
